Skip to main navigation Skip to search Skip to main content

A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry

  • Burcu F. Darst
  • , Raymond Hughley
  • , Aaron Pfennig
  • , Ujani Hazra
  • , Caoqi Fan
  • , Peggy Wan
  • , Xin Sheng
  • , Lucy Xia
  • , Caroline Andrews
  • , Fei Chen
  • , Sonja I. Berndt
  • , Zsofia Kote-Jarai
  • , Koveela Govindasami
  • , Jeannette T. Bensen
  • , Sue A. Ingles
  • , Benjamin A. Rybicki
  • , Barbara Nemesure
  • , Esther M. John
  • , Jay H. Fowke
  • , Chad D. Huff
  • Sara S. Strom, William B. Isaacs, Jong Y. Park, Wei Zheng, Elaine A. Ostrander, Patrick C. Walsh, John Carpten, Thomas A. Sellers, Kosj Yamoah, Adam B. Murphy, Maureen Sanderson, Dana C. Crawford, Susan M. Gapstur, William S. Bush, Melinda C. Aldrich, Olivier Cussenot, Gyorgy Petrovics, Jennifer Cullen, Christine Neslund-Dudas, Rick A. Kittles, Jianfeng Xu, Mariana C. Stern, Anand P. Chokkalingam, Luc Multigner, Marie Elise Parent, Florence Menegaux, Geraldine Cancel-Tassin, Adam S. Kibel, Eric A. Klein, Phyllis J. Goodman, Janet L. Stanford, Bettina F. Drake, Jennifer J. Hu, Peter E. Clark, Pascal Blanchet, Graham Casey, Anselm J.M. Hennis, Alexander Lubwama, Ian M. Thompson, Robin J. Leach, Susan M. Gundell, Loreall Pooler, James L. Mohler, Elizabeth T.H. Fontham, Gary J. Smith, Jack A. Taylor, Laurent Brureau, William J. Blot, Richard Biritwum, Evelyn Tay, Ann Truelove, Shelley Niwa, Yao Tettey, Rohit Varma, Roberta McKean-Cowdin, Mina Torres, Mohamed Jalloh, Serigne Magueye Gueye, Lamine Niang, Olufemi Ogunbiyi, Michael Oladimeji Idowu, Olufemi Popoola, Akindele O. Adebiyi, Oseremen I. Aisuodionoe-Shadrach, Maxwell Nwegbu, Ben Adusei, Sunny Mante, Afua Darkwa-Abrahams, Edward D. Yeboah, James E. Mensah, Andrew Anthony Adjei, Halimatou Diop, Michael B. Cook, Stephen J. Chanock, Stephen Watya, Rosalind A. Eeles, Charleston W.K. Chiang, Joseph Lachance, Timothy R. Rebbeck, David V. Conti, Christopher A. Haiman
  • University of Southern California
  • Georgia Institute of Technology
  • Dana-Farber Cancer Institute
  • National Institutes of Health
  • The Institute of Cancer Research
  • Royal Marsden NHS Foundation Trust
  • University of North Carolina at Chapel Hill
  • University of North Carolina at Chapel Hill
  • Henry Ford Health System
  • Stanford University
  • University of Tennessee Health Science Center
  • University of Texas MD Anderson Cancer Center
  • Johns Hopkins University
  • Moffitt Cancer Center
  • Vanderbilt University
  • Northwestern University
  • Meharry Medical College
  • Case Western Reserve University
  • American Cancer Society
  • Sorbonne Université
  • Uniformed Services University of the Health Sciences
  • City of Hope National Med Center
  • NorthShore University HealthSystem
  • University of California at Berkeley
  • University Rennes
  • Institut national de la recherche scientifique
  • Université Paris-Saclay
  • Brigham and Women’s Hospital
  • Washington University St. Louis
  • Cleveland Clinic Foundation
  • Fred Hutchinson Cancer Research Center
  • University of Washington
  • University of Miami
  • Atrium Health/Levine Cancer Institute
  • Université des Antilles
  • University of Virginia
  • Stony Brook University
  • University of the West Indies
  • Makerere University
  • University of Texas Health Science Center at San Antonio
  • Roswell Park Cancer Institute
  • Louisiana State University Health Sciences Center
  • Korle Bu Teaching Hospital
  • Westat
  • University of Ghana
  • CHA Hollywood Presbyterian Medical Center
  • Hôpital Général Idrissa Pouye
  • University of Ibadan
  • University of Abuja, Gwagwalada
  • 37 Military Hospital
  • Centre hospitalier universitaire Aristide Le Dantec de Dakar
  • Uro Care

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Abstract

A rare African ancestry–specific germline deletion variant in HOXB13 (X285K, rs77179853) was recently reported in Martinican men with early-onset prostate cancer. Given the role of HOXB13 germline variation in prostate cancer, we investigated the association between HOXB13 X285K and prostate cancer risk in a large sample of 22 361 African ancestry men, including 11 688 prostate cancer cases. The risk allele was present only in men of West African ancestry, with an allele frequency in men that ranged from 0.40% in Ghana and 0.31% in Nigeria to 0% in Uganda and South Africa, with a range of frequencies in men with admixed African ancestry from North America and Europe (0–0.26%). HOXB13 X285K was associated with 2.4-fold increased odds of prostate cancer (95% confidence interval [CI] = 1.5-3.9, p = 2 × 10−4), with greater risk observed for more aggressive and advanced disease (Gleason ≥8: odds ratio [OR] = 4.7, 95% CI = 2.3–9.5, p = 2 × 10−5; stage T3/T4: OR = 4.5, 95% CI = 2.0–10.0, p = 2 × 10−4; metastatic disease: OR = 5.1, 95% CI = 1.9–13.7, p = 0.001). We estimated that the allele arose in West Africa 1500–4600 yr ago. Further analysis is needed to understand how the HOXB13 X285K variant impacts the HOXB13 protein and function in the prostate. Understanding who carries this mutation may inform prostate cancer screening in men of West African ancestry. Patient summary: A rare African ancestry–specific germline deletion in HOXB13, found only in men of West African ancestry, was reported to be associated with an increased risk of overall and advanced prostate cancer. Understanding who carries this mutation may help inform screening for prostate cancer in men of West African ancestry.

Original languageEnglish
Pages (from-to)458-462
Number of pages5
JournalEuropean Urology
Volume81
Issue number5
DOIs
StatePublished - May 2022

Keywords

  • African ancestry
  • Allelic age
  • Genetics
  • HOXB13
  • Health disparities
  • Prostate cancer
  • Rare genetic variants

Fingerprint

Dive into the research topics of 'A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry'. Together they form a unique fingerprint.

Cite this